期刊文献+

紫草清癜汤加减治疗过敏性紫癜的临床分析 被引量:2

Clinical Analysis of Modified Zicao Qingdian Tang in Treatment of Henoch Schonlein Purpura
下载PDF
导出
摘要 目的探析紫草清癜汤加减治疗小儿过敏性紫癜的临床效果。方法方便选取该院在2012年1月—2016年12月期间就诊的78例小儿过敏性紫癜患儿,将其随机分为治疗组和对照组,各为39例,对照组采取西医治疗,治疗组给予紫草清癜汤加减治疗,比较两组治疗效果、皮肤紫癜消失时间、腹痛关节痛消失时间及治愈时间等。结果治疗组总有效率为92.31%与对照组74.36%比较差异有统计学意义(P<0.05);治疗组皮肤紫癜消失时间(7.3±1.4)d、腹痛消失时间(3.1±1.5)d、关节痛消失时间(8.4±1.4)d与对照组比较差异有统计学意义(P<0.05);治疗组不良反应发生率2.56%与对照组20.51%比较差异有统计学意义(P<0.05)。结论紫草清癜汤加减治疗小儿过敏性紫癜的临床效果确切,缩短其病程,不良反应少,值得临床推广。 Objective To study the clinical effect of modified zicao qingdian tang in treatment of henoch schonlein purpura.Methods 78 cases of children with henoch schonlein purpura diagnosed in our hospital from January 2012 to December 2016 were selected and randomly divided into two groups with 39 cases in each, the control group and the treatment group were respectively treated with western medicine and modified zaicao qingdian tang, and the treatment effect, disappearance time of skin purpura and bellyache and joint pain and cure time were compared between the two groups. Results The difference in the total treatment effective rate between the treatment group and the control group was obvious(92.31% vs 74.36%)(P〈0.05), and the disappearance time of skin purpura and bellyache and joint pain in the treatment group was respectively(7.3±1.4)d,(3.1±1.5)d and(8.4±1.4)d, and the differences between the two groups were obvious(P〈0.05), and the difference in the incidence rate of adverse reactions between the treatment group and the control group was obvious(2.56% vs20.51%)(P〈0.05). Conclusion The clinical effect of modified zicao qingdian tang in treatment of henoch schonlein purpura is definite, which can shorten the disease course with fewer adverse reactions, and it is worth clinical promotion.
作者 李德秀
出处 《中外医疗》 2017年第18期175-177,共3页 China & Foreign Medical Treatment
关键词 紫草清癜汤 小儿过敏性紫癜 临床效果 Zicao qingdian tang Children with henoch schonlein purpura Clinical effect
  • 相关文献

参考文献6

二级参考文献37

  • 1郑虎占 董泽宏 佘靖.中药现代研究与应用[M].北京:学苑出版社,1997.1497-1503,2138-2148,3694—3707.
  • 2胡亚美,江载芳,诸福荣.实用儿科学.北京:人民卫生出版社,2003.
  • 3叶任高,陆再英.内科学[M].6版.北京:人民卫生出版社,2005.948-987.
  • 4胡亚美.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2006:617
  • 5南京中医药大学.中药大辞典[M].上海:上海科学技术出版社,2012:23-24.
  • 6Reamy Bv,Williams PM,Lindsay TJ.Henoch-Schonlein Purpura [J].Am Faro Physician,2009,80(7):697-704.
  • 7Ece A,Kelekci S,Hekimoglu Aet al.Neutrophil activation,Protein Oxidation,and ceruloplasmin levels in children with Henoch-Schonlein Purpura [J].Pediatr Nephrol,2007,22(8):1151-1157.
  • 8Bogdanovic R.Henoch-Schonlein purpura nephritis in children:risk factors,prevention and treatment[J].Acta Paediatr,2009,98(12):1882-1889.
  • 9Tabel Y,Inanc FC,Dogan DG.Clinical features of children with Henoch-Schonlein purpura:risk factors associated with re-nal involvement[J].Iran J Kidney Dis,2012,6(4):269-274.
  • 10中华人民共和国卫生部.涉及人的生物医学研究伦理审查办法(试行)[S].(2007-03-26)[2010-04-05].http://www.moh.gov.cn/qjjys/s3581/200804/b9f1bfee4ab344ec892e68097296e2a8.shtml.

共引文献44

同被引文献16

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部